AzTrials
AzTrials

Diabetes or Diabetes PreventionPhase 2EWLWNCT00561158

Eat Well Live Well Nutrition Program

A Phase 2 study testing Eat Well Live Well Nutrition Program in people with Diabetes or Diabetes Prevention, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to develop and evaluate a dietary change program specifically for low-income, African-American women who are at risk for developing diabetes due to obesity. Read more about this study

Who is it for?
Ages 25 to 55 years, women onlyHealthy volunteers can take part
Conditions the study is for
Diabetes or Diabetes Prevention
What is being tested?
Eat Well Live Well Nutrition Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
398 participants
Where
No sites listed yet
Study dates
Jun 1994to May 1998
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 55 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • African-American Women
  • Aged 25-55 years
  • No current diabetes, obese (20% over ideal body weight)
  • In community neighborhoods

Who cannot join

None listed.

About this study

Official title: Dietary Changes in African American Women By Activation

The purpose of the study is to develop and evaluate a dietary change program specifically for low-income, African-American women who are at risk for developing diabetes due to obesity. The program uses an innovative approach that emphasizes risk awareness, self-efficacy, and skills training through active learning exercises related to healthy eating. The program is delivered by peer educators in the community and addresses economic and cultural factors that are very important to program participants.

Being tested
Eat Well Live Well Nutrition Program
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eat Well Live Well Nutrition ProgramBehavioural

    12 sessions (6 group and 6 individual)over a period of 3 months with a 3 month follow-up period. The group sessions involve active learning exercises crucial to learning and utilizing nutrition information.

    The group sessions included are:

    • Rate Your Plate: determining high fat foods
    • Label Reading: reading food labels
    • Comparison Shopping: using unit pricing labels maximize nutritional value on a limited income
    • Recipe Modification: preparing old recipes in new ways to reduce fat
    • Eating Out: order healthier fast foods
    • Coping with High Risk Situations: coping with situations in which these new habits may be threatened

    Six individual sessions will introduce participants to low fat eating patterns or ways to lower fat in their diet, including:

    • Substituting fat-modified foods for high fat foods
    • Avoiding fat as a seasoning or flavoring
    • Avoiding fried foods
    • Modifying meat
    • Replacing high fat foods with fruits, vegetables, grains and breads
Study groups in NCT00561158
Study groupRoleWhat they receive
AExperimentalNot described
Receives: Behavioral: Eat Well Live Well Nutrition Program
2No interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight & Body Mass Index (BMI)

    Measured: pre-, post and three month follow-up

  2. Fat intake (measured by Food Frequency Questionnaire) including: percent calories from fat, percent calories from saturated fat.

Secondary outcomes (5)
  1. Depressive symptoms (C-ESD)

    Measured: pre-, post and three month follow-up

  2. Dietary Knowledge: ten items that test knowledge of: i) fat in foods that are specific to target population; ii) Label Reading; iii) modifying recipes to lower fat content; and iv) saturated versus unsaturated fats

    Measured: pre-, post and three month follow-up

  3. Eating Habits: assessed using Eating Patterns Questionnaire, a 1993 revised version of Food Habits Questionnaire developed by Kristal, Shattuck & Henry

    Measured: pre-, post and three month follow-up

  4. Attitudes about fat in diet

  5. Cultural relevancy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2007 (estimated)
  2. Study startJun 1994
  3. Study completionMay 1998

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
398 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00561158
Sponsor's protocol ID
DK48134 (completed)
Other IDs
R01DK048143
Acronym
EWLW
Status last verified
Jan 2010
First submitted
19 Nov 2007
Last updated
15 Jan 2010
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Eat Well Live Well Nutrition Program in people with Diabetes or Diabetes Prevention, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jan 2010. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight & Body Mass Index (BMI) (time frame: pre-, post and three month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2010.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in